DISTRIBUTOR AGREEMENT

                                                                   EXHIBIT 10.20

               CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY
             WITH THE SECURITIES AND EXCHANGE COMMISSSION. ASTERISKS
                                DENOTE OMISSIONS.

                              DISTRIBUTOR AGREEMENT

      THIS  AGREEMENT  ("Agreement")  is made and entered into as of this __31__
day of  October,  2005  (hereinafter,  the  "EFFECTIVE  DATE")  by  and  between
Cytomedix,  Inc.  ("CYTOMEDIX"),  416 Hungerford  Drive,  Suite 330,  Rockville,
Maryland  20850,  and  National  Wound  Therapies,  LLC  ("DISTRIBUTOR"),   1771
International Parkway, Suite 121 Richardson, Texas 75081.

      WHEREAS,  Cytomedix is the owner of certain patent and other  intellectual
property rights in the Products; and

      WHEREAS,  due  to  their  unique  nature,  the  Products  require  special
distribution services and post-sale support and service; and

      WHEREAS, Cytomedix wishes to have its Products distributed to the Selected
Facilities  by means of a  distributor  with the ability to promote,  sell,  and
distribute  the  Products,  adequately  train  its  personnel  and the  Selected
Facilities in the use and  application  of the Products,  and provide  post-sale
service and support of the Products; and

      WHEREAS,  the  Distributor  is a  distributor  of medical  products with a
distribution  network  in place  sufficient  to cover the  Selected  Facilities;
Distributor has the ability,  expertise, and desire to promote, sell, distribute
the Products to the Selected Facilities,  adequately train its personnel and the
personnel of the Selected Facilities in the use and application of the Products,
and  provide  post-sale  service and support of the  Products;  and  Distributor
wishes to serve as the distributor  for the Products to the Selected  Facilities
listed in Exhibit "A"; and

      WHEREAS,  Cytomedix and the Distributor  wish to enter into this Agreement
to  provide  a  full,   written   statement  of  their  respective   rights  and
responsibilities under this arrangement.

      NOW,  THEREFORE,  in  consideration  of the  above  recitals,  the  mutual
promises  contained  herein,  and other  good and  valuable  consideration,  the
receipt and sufficiency of which are hereby  acknowledged,  the parties agree as
follows:


<PAGE>


1.    DEFINITIONS.

As used herein, the following terms shall have the meanings set forth below:

      A.    "Selected  Facilities"  shall  mean  those  nursing  homes,  skilled
            nursing,  long-term acute care and inpatient rehabilitation hospital
            facilities  identified in Exhibit "A" and those facilities as may be
            agreed upon by the parties from time to time.

      B.    "MSRP"  shall  mean  Cytomedix's   suggested  retail  price  of  the
            Products,  as established and amended by Cytomedix from time to time
            which, in any event,  shall be not less than twice the price charged
            to Distributor.

      C.    "Products" or "Kit(s)" shall mean the  AutoloGel(TM)  Supply Kit and
            other  disposables,  hardware and  reagents as may be developed  and
            improved by Cytomedix from time to time.

      D.    "Term" shall mean the period described in Section 13 hereof.

      E.    "Termination  Date"  shall  mean  December  31,  2009,  unless  this
            Agreement shall be renewed in accordance with Section 13B(ii).

      F.    "Minimum Order Quantity" shall mean those  quantities of Centrifuges
            and Kits described in Exhibit "C".

      G.    "Additional  Products" shall mean any amount of Products  ordered by
            Distributor in excess of the Minimum Order Quantity.

      H.    "Other  Facilities"  shall  mean  nursing  homes,  skilled  nursing,
            long-term  acute  care,  inpatient   rehabilitation   hospitals,  or
            facilities  in which a  physician  or  practitioner  from a Selected
            Facility also provides  services,  other than a Protected  Facility.
            Other Facilities are not Selected Facilities but may become Selected
            Facilities according to the provisions of Section 2.

      I.    "Protected  Facilities"  shall mean any and all  facilities in which
            Cytomedix has granted or shall grant (prior to the  establishment of
            a Selected Facility) to other distributors or agents an exclusive or
            otherwise protected right to sell or distribute products.  Protected
            Facilities are set forth in Exhibit E.


<PAGE>

      J.    "Affiliates"  shall  mean  any  entity  that is owned by or is under
            common ownership with Distributor  where "own" or "ownership"  means
            possession of at least 50% of outstanding voting securities.

2.    APPOINTMENT.

      A. Exclusive  Distributor of Products to the Selected Facilities.  Subject
to the terms and  conditions  contained in this  Agreement,  Cytomedix  appoints
Distributor  as its  independent  and sole  distributor  for the Products to the
Selected  Facilities  with  exclusive  rights  to  purchase  the  Products  from
Cytomedix for resale to the Selected  Facilities for the Term of this Agreement,
and Distributor  hereby accepts such appointment to sell and market the Products
under Cytomedix's name,  logotype,  and trademark.  Distributor's sole authority
shall be to solicit orders for the Products from the Selected  Facilities and to
offer  post-sale  support and service to the Selected  Facilities  in accordance
with the terms of this  Agreement.  Distributor  shall not have the authority to
make any commitments whatsoever on behalf of Cytomedix.  The Selected Facilities
in Exhibit A are  designated  as Selected  Facilities  for the first twelve (12)
months of this  Agreement.  If at the end of the first  year of this  Agreement,
Distributor has provided  Cytomedix with documented  proof that  Distributor has
made a  demonstration  of the  Cytomedix  AutoloGel  Product to at least  Thirty
Percent (30%) of the chains (or their  successors in interest) listed on Exhibit
A, the Selected  Facilities shall remain designated  Selected  Facilities for an
additional  twelve  (12)  months.  If at the  end of the  second  year  of  this
Agreement,  Distributor has provided Cytomedix with documented proof that during
the  first  two  years  of  this  Agreement  that  the  Distributor  has  made a
demonstration of the Cytomedix AutoloGel Product to at least Sixty-Percent (60%)
of the  chains  (or their  successors  in  interest)  listed on  Exhibit  A, the
Selected   Facilities  shall  remain  designated   Selected  Facilities  for  an
additional  twelve  (12)  months.  If at the  end  of the  third  year  of  this
Agreement,  Distributor has provided Cytomedix with documented proof that during
the  first  three  years  of this  Agreement  that  the  Distributor  has made a
demonstration  of the  Cytomedix  AutoloGel  Product to at least  Ninety-Percent
(90%) of the chains (or their  successors in interest)  listed on Exhibit A, the
Selected   Facilities  shall  remain  designated  Selected  Facilities  for  the
remainder of this Agreement.  In any event,  for every Chain (or their successor
in interest) set forth on Exhibit A, for which Distributor has obtained bonafide
sales of Cytomedix  Product,  such Chain (or their  successor in interest) shall
remain a Selected Facility for the entire term of this Agreement. Demonstrations
by Distributor,  sales presentations by Distributor and written documentation of
such shall be provided by Distributor in accordance with Section 4 and Exhibit D
of this Agreement.


<PAGE>

      B. Reserved  Rights.  Distributor  understands  that its exclusive  rights
provided in Section  2.A.  above do not govern  solicitation  of or sales of the
Product to  facilities  other than the Selected  Facilities  including,  but not
limited to, facilities in the same geographic area which may compete with one or
more of the Selected Facilities.  Cytomedix may, in its sole discretion, appoint
or  secure  representation  to  solicit  any  customers  that  are not  Selected
Facilities,  sell the Products to those customers, and provide post-sale service
and support to those customers without violating  Distributor's exclusive rights
in the Selected  Facilities.  The Distributor is approved and authorized to sell
the Product to other customers and/or provide  post-sale  support and service to
customers beyond the Selected Facilities as provided herein.

      C.  Distributor  of Products to Other  Facilities.  Cytomedix  agrees that
Distributor  may accept  orders  from and resell  Products  to Other  Facilities
provided  that the sales to such Other  Facilities do not violate any current or
future  agreement  (made  prior to the  establishment  of a  Selected  Facility)
between  Cytomedix  and any third  party  granting  exclusive  rights to sell or
distribute  Products.  Other  Facilities  shall become  Selected  Facilities  by
Cytomedix  granting express consent;  or upon Distributor  obtaining the sale of
twelve (12) Kits within six (6) months to such Other  Facility,  whereupon  such
Other Facility will become an interim Selected Facility for a period of 180 days
from the date of the sale of the first Kit. That facility will remain a Selected
Facility for as long as Distributor  continues to sell at least twelve (12) Kits
to such facility  every 180 days.  The provision of this Section 2.C.  regarding
loss of status as a Selected  Facility  for failure of  Distributor  to meet the
minimum  sales  requirements  of twelve (12) Kits every six (6) months  shall be
applicable only to the Other Facilities that become Selected Facilities pursuant
to this Section 2.C.

      D.  Distributor and Affiliates  Bound to this  Agreement.  Distributor may
solicit sales  through  Affiliates  in which case such  Affiliates  would become
subject to the terms of this Agreement,  (except the Minimum Ordering  Quantity,
it being  the  intent  that  Distributor's  Affiliates  shall be used to  assist
Distributor in meeting the order requirements).


<PAGE>

3.    SALE OF THE PRODUCTS.

      A.    Prices and Terms of Sale.

            (i)  For  the  Term  of  this  Agreement,  Cytomedix  shall  sell to
      Distributor the  AutoloGel(TM)  Supply Kit and reagents for ***** per kit.
      In the event  Cytomedix  should lower the MSRP,  Cytomedix shall lower the
      price at which it sells the Products to the  Distributor so that the price
      at which Cytomedix sells the Products to Distributor  remains ***** of the
      MSRP. In the event that the cost of production of the AutoloGel(TM) Supply
      Kit including reagents  increases or decreases,  said increase or decrease
      will  be  adequately  documented  and  passed  on to  Distributor  with  a
      concomitant  increase  or  decrease.  In any event,  the price  charged to
      Distributor   shall  be  equal  to  the  lowest  price  charged  to  other
      Distributors servicing similar markets.

            (ii) Distributor shall pay ***** for each  AutoloGel(TM)  Processing
      Unit (the  "Centrifuge"),  and  Distributor  shall be required to purchase
      Centrifuges  from Cytomedix for the Selected  Facilities  where necessary.
      This one-time payment gives Distributor ownership of each Centrifuge.

            (iii) In order to retain exclusivity and non-exclusivity status with
      respect to Selected  Facilities and Other Facilities  described in Section
      2, Distributor shall purchase,  on a semi-annual  basis, from Cytomedix an
      agreed upon  Minimum  Order  Quantity of Kits which is outlined in Exhibit
      "C", defined as the Minimum Order Requirements of Distributor.

            (iv) Cytomedix  shall,  at  Distributor's  option,  ship directly to
      Distributor or a purchasing  customer at the shipping  address provided by
      Distributor.   Cytomedix  shall  provide  Distributor  with  its  delivery
      schedules and its standard  terms and  conditions of sale, as  established
      from time to time.  Distributor  may elect to have  Products  shipped  via
      ground  or air  freight,  but  Distributor  shall be  responsible  for all
      shipping,  handling,  insurance, import duties, taxes, and clearance costs
      relating to its orders of the  Products.  Ownership of the Products  shall
      pass when invoiced  Product is received by  Distributor or its customer in
      acceptable condition.

      B. Initiationt 6 12 of Supply.

<PAGE>

            (i) Upon  execution  of this  Agreement,  Distributor  shall  pay to
      Cytomedix the 50% price of the Minimum Order Quantity for the Products and
      Centrifuges to be supplied during the first three months hereunder. Within
      fifteen  (15)  days of  receipt  of  shipment,  Distributor  will  pay the
      remaining balance. For all months after the third month of this Agreement,
      Distributor  shall pay by the  Fifteenth  (15th) day of each month for the
      Products and Centrifuges following shipment and receipt of an invoice from
      Cytomedix.  Should  Distributor  require Products in excess of the Minimum
      Order Quantity,  Distributor  shall order Additional  Products pursuant to
      the provisions of this section.

            (ii) Upon execution of this  Agreement,  Cytomedix shall provide the
      Minimum Order Quantity to Distributor  for the current month.  Thereafter,
      Cytomedix  shall  supply the Minimum  Order  Quantity on a monthly  basis.
      Cytomedix  shall  deliver  Additional   Products  ordered  by  Distributor
      pursuant to the terms of this section.

      C. Orders.  This Agreement  shall be deemed an order for the Minimum Order
Quantity  as  described  in  Exhibit  "C"  for  the  first  three  months.   The
commencement date for the Minimum Order  requirements  shall be January 1, 2006.
Distributor shall place all other Minimum Order Quantities, including orders for
any Additional Products via the Cytomedix order form two months in advance. Each
order of the  Products,  including  Additional  Products  shall be  governed  by
delivery  schedules and terms and  conditions in effect at the time the order is
accepted by  Cytomedix,  and all  quotations  by  Distributors  shall  contain a
statement  to that  effect.  Cytomedix  shall ship and invoice the  Products and
Additional  Products  on or near the  first of the  month for which the order is
required. Distributor shall pay the invoice by the Fifteenth (15th) of the month
for which the order is  received  by  Distributor.  After the first year of this
Agreement,  Distributor shall pay the invoice within thirty (30) days of receipt
of invoice.

      D. Acceptance.  All orders received from  Distributor  shall be subject to
acceptance by Cytomedix at its principal  office provided that Cytomedix  agrees
to use  commercially  reasonable  best efforts to fulfill  reasonable  orders of
Distributor.

      E. Invoices.  Cytomedix shall render all invoices on shipped Products on a
monthly basis  directly to  Distributor.  Payments  shall be made by Distributor
directly to Cytomedix.  Full  responsibility  for  collection  from the Selected
Facilities rests with Distributor,  and a Customer's  failure to pay Distributor
does not affect Distributor's obligation to pay Cytomedix. Payment shall be made
to Cytomedix by Distributor within fifteen (15) days of the date of the invoice.
After the first year of this Agreement, Distributor shall pay the invoice within
thirty (30) days of receipt of invoice.  Distributor  shall pay late  charges on
all unpaid and overdue  invoices of twelve  percent (12%) per annum or otherwise
the  maximum  rate  permitted  by  applicable  law to be charged  for unpaid and
overdue invoices.


<PAGE>

      F.  Inquiries  from   Customers   other  than  the  Selected   Facilities.
Distributor shall not solicit sales from Protected Facilities, without the prior
written consent of Cytomedix.

      G.  Support.  Distributor  shall  provide  reasonable  sales and  clinical
support to the Selected  Facilities  in order to maintain  and develop  Customer
relationships and promote sales of the Products at its sole expense.

4.    RESPONSIBILITIES OF DISTRIBUTOR.

      A. Necessary  Authorizations.  Distributor  shall acquire and maintain all
licenses,  permits, consents or authorizations necessary to sell the Products to
any and all of the Selected  Facilities.  Distributor shall comply with all laws
and regulations affecting its business during the Term of this Agreement.

      B. Expense of Doing Business.  Distributor  shall bear the entire cost and
expense  of  conducting  its  business  in  accordance  with  the  terms of this
Agreement.  All financial and other  obligations  associated with  Distributor's
business are the sole responsibility of Distributor.

      C.  Facilities.  Distributor  shall  provide  itself  with,  and be solely
responsible for, (i) such facilities,  employees, and business organization, and
(ii) such permits,  licenses,  and other forms of clearance from governmental or
regulatory  agencies,  if any, as are necessary for the conduct of Distributor's
business operations in accordance with this Agreement.

      D.  Promotional   Materials.   All  promotional   materials   utilized  by
Distributor  relating to Cytomedix or the Products shall have the prior approval
of Cytomedix which shall not be withheld unreasonably. Distributor shall not use
any notice, circular, advertisement, letter or any oral or written communication
regarding  Cytomedix or the Products  without the prior  reasonable  approval of
Cytomedix.  In no event shall Distributor make any representation,  guarantee or
warranty concerning the Products or Cytomedix except as expressly and reasonably
authorized by Cytomedix. In no event shall Distributor engage in any promotional
activities that violate any law, rule, or regulation  applicable to Distributor,
Cytomedix or the Products,  Including without  limitation the Federal Food, Drug
and  Cosmetic  Act.  21 U.S.C.  Sec.  321 et seq.,  and the  Federal  Healthcare
Anti-Kickback Law, 42 U.S.C. Sec. 1320a-7b.


<PAGE>

      E. Training.

            (i)  Distributor  shall  be  responsible  for  training  all  of its
      personnel who promote, sell, support and service the Products so that they
      are  knowledgeable  about the Products and can adequately  promote,  sell,
      support  and  service  the  Products  as  required  under this  Agreement.
      Distributor  shall be responsible  for training  appropriate  personnel on
      compliance  with laws  applicable  to the  promotion  and marketing of the
      products,  including  without  limitation  the laws described in Section D
      above.

            (ii)  Distributor  shall be  responsible  for  training the Selected
      Facilities in the use and application of the Products.

            (iii) As provided in Section  5.B.,  Cytomedix  shall  cooperate and
      assist reasonably in effecting the training required by this Section 4.E.

      F. Advising of Changes.  Distributor,  to the best of its knowledge, shall
promptly  advise  Cytomedix  of  (i)  any  changes  in   Distributor's   status,
organization,  key personnel,  and similar matters,  (ii) any changes in the key
personnel, organization, and status of any of the Selected Facilities, (iii) any
change in Distributor's ability to sell Products.

      G. Advising of Changes.  Cytomedix,  to the best of its  knowledge,  shall
promptly  advise   Distributor  of  (i)  any  changes  in  Cytomedix's   status,
organization,  key  personnel  or  similar  matters,  and  (ii) any  changes  in
Cytomedix's ability to sell products.

      H.  Books  and  Records.  Distributor  shall  participate  with  Cytomedix
regarding inquiries,  transactions,  sales and other proceedings relating to the
Products.  Distributor  shall maintain and make available to Cytomedix  accurate
books,  records,  and accounts relating to the sales and revenues of Distributor
with respect to the Products provided to the Distributor. Distributor shall also
maintain a record of any customer  complaints  regarding  either the Products or
Cytomedix and immediately  forward to Cytomedix the information  regarding those
complaints.


<PAGE>

      I. Consulting.  Distributor  shall  participate  with Cytomedix  regarding
quality control and product  performance during the Term of the Agreement.  This
participation shall generally include:

            (i) Review of the sales  practices of competitors  with the identity
      of  such   competitors   identified  and  agreed  upon  by  Cytomedix  and
      Distributor;

            (ii) Advice concerning:

                  (a) pricing and  packaging  of  advertising  sales;  (b) sales
                  promotions;

                  (c) ongoing  supervision  of the sales  effort at the Selected
                  Facilities.

                  (d)  advice   concerning   anything  to  provide   competitive
                  advantage.

      J.  Availability.  Distributor  shall be available for telephone review of
any matters related to this Agreement at reasonable times.

      K.  Recalls.   In  the  event  Cytomedix  recalls  any  Products  sold  by
Distributor,  Distributor  shall  reasonably  assist Cytomedix with such recall.
Cytomedix agrees to give  Distributor  prompt notice in the event that Cytomedix
recalls any  Product,  or ceases or suspends  the sale of any Product due to any
problem which relates to such Product's  efficacy or patient safety. In order to
assist Cytomedix in the event of a recall, Distributor shall maintain a complete
and current listing of the locations of all Products in Distributor's inventory,
and the  names of the  Selected  Facilities  who have  purchased  Products  from
Distributor.

      L.  Disparaging  Comments.  At all times during the Term of this Agreement
and thereafter,  the  Distributor  shall not disparage the name or reputation of
Cytomedix  or the  Products,  and  Cytomedix  shall  not  disparage  the name or
reputation of the Distributor.

      M. Competition.  Distributor agrees not to sell,  promote,  manufacture or
have  manufactured  any products or processes  that are covered by any Cytomedix
patent unless  Distributor is  specifically  licensed to do such under agreement
with Cytomedix.


<PAGE>